|
|
||||
![]() | ||||
|
|
|
Select from the search options to widen or narrow the search results.
Prostate Cancer (ECOG 3805) For patients with widespread prostate cancer, to evaluate if the addition of chemotherapy to hormone ablative therapy compared to hormone ablative therapy alone improves overall outcome. Principal Investigator: Dhimant Patel MD For more information please contact Kate Newbanks 920-288-4115 kate.newbanks@aurora.org or Lori McElrone 920-288-4174 lori.mcelrone@aurora.org Clinical trial location(s)AMG - ABMC (incl. VLCC) Clinical trial location(s)AMG - ABMC (incl. VLCC)2845 Greenbrier Road Green Bay, WI 54308-8900
[ previous page ]
|
||
|
|
|
|||